Karuna Therapeutics, Inc. - stock earnings
KRTX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | - / -3.0267000000 | - | - / 3.4 million | - |
KRTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -113.8 million USD | ? USD |
| 2023Q3 | -119.1 million USD | ? USD |
| 2023Q2 | -103.2 million USD | ? USD |
| 2023Q1 | -86.1 million USD | 654000 USD |
| 2022Q4 | -76.2 million USD | 5.3 million USD |
| 2022Q3 | -69.0 million USD | 81000 USD |
| 2022Q2 | -64.9 million USD | 5.3 million USD |
| 2022Q1 | -57.6 million USD | ? USD |
| 2021Q4 | -28.0 million USD | 37.0 million USD |
| 2021Q3 | -50.9 million USD | ? USD |
| 2021Q2 | -34.4 million USD | ? USD |
| 2021Q1 | -30.5 million USD | ? USD |
| 2020Q4 | -24.0 million USD | ? USD |
| 2020Q3 | -18.8 million USD | ? USD |
| 2020Q2 | -17.0 million USD | ? USD |
| 2020Q1 | -8.7 million USD | ? USD |
| 2019Q4 | -7.8 million USD | ? USD |
| 2019Q3 | -9.0 million USD | ? USD |
| 2019Q2 | -15.1 million USD | ? USD |
| 2019Q1 | -12.0 million USD | ? USD |
| 2018Q4 | -8.3 million USD | ? USD |
| 2018Q3 | -6.2 million USD | ? USD |
| 2018Q2 | -539000 USD | ? USD |
| 2018Q1 | -2.4 million USD | ? USD |
KRTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -433.7 million USD | 654000 USD |
| 2022 | -276.3 million USD | 10.6 million USD |
| 2021 | -143.8 million USD | 37.0 million USD |
| 2020 | -68.6 million USD | ? USD |
| 2019 | -44.8 million USD | ? USD |
| 2018 | -17.5 million USD | ? USD |
| 2017 | -6.0 million USD | ? USD |
KRTX
Price: $329.83
52 week price:
Earnings Per Share: -10.94 USD
P/E Ratio: -29.07
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 180800
Market Capitalization: 12.1 billion